Rehabilitation challenges in multiple sclerosis

Annals of Indian Academy of Neurology

Volumn 12, Issue 4, 2009, Pages 296-306

  Burks, Jack S ^a,b   Bigley, George Kim ^a   Hill, Harry Haydon ^a,c  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b Multiple Sclerosis Association of America (MSAA)   (United States)

^c Rehabilitation Hospital   (United States)

Author keywords

Multiple sclerosis; Rehabilitation

Indexed keywords

4 AMINOPYRIDINE; AMANTADINE; ANTIDEPRESSANT AGENT; BACLOFEN; BISACODYL; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESMOPRESSIN; DOCUSATE SODIUM; ENEMA; EX LAX; GABAPENTIN; GLYCEROL; ISPAGULA; MAGNESIUM HYDROXIDE; METHYLCELLULOSE; METHYLPHENIDATE; MODAFINIL; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; PAPAVERINE; PERI COLACE; PREGABALIN; PROSTAGLANDIN E1; SENNA EXTRACT; SILDENAFIL; TADALAFIL; TAMSULOSIN; TERAZOSIN; TOLTERODINE; UNCLASSIFIED DRUG; VARDENAFIL;

BALANCE IMPAIRMENT; BEDTIME DOSAGE; BEHAVIOR DISORDER; BLADDER AND BOWEL MANAGEMENT; BLADDER DYSFUNCTION; BLADDER FUNCTION; CAREGIVER; CATHETERIZATION; CLINICAL TRIAL; COGNITION; DAILY LIFE ACTIVITY; DEPRESSION; DISABILITY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DYSARTHRIA; DYSPHASIA; EMPLOYMENT; EXERCISE; FAMILY; FATIGUE; GAIT; HABITUATION; HEALTH CARE PERSONNEL; HUMAN; HUMAN RELATION; HYPOTONIC BLADDER; INTERDISCIPLINARY COMMUNICATION; INTESTINE FUNCTION; LOW DRUG DOSE; MOOD; MULTIPLE SCLEROSIS; NURSE; OCCUPATIONAL THERAPIST; PAIN; PATIENT EDUCATION; PATIENT SAFETY; PHYSICIAN; PHYSIOTHERAPIST; PSYCHOTHERAPIST; QUALITY OF LIFE; RECREATION; RECREATIONAL THERAPY; REVIEW; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; SLEEP DISORDER; SOCIAL WORKER; SPASTICITY; SPEECH; SPEECH REHABILITATION; SWALLOWING; SYMPTOM; TRAFFIC AND TRANSPORT; VOCATIONAL REHABILITATION; WALKING DIFFICULTY; WEAKNESS; WHEELCHAIR;

EID: 72949118258     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.58273     Document Type: Review

References (72)

1. Putnam M, Tang F. Long-term care planning and preparation among persons with multiple sclerosis. Home Health Care Serv Q 2008;27:143-165
2. Cohen BA. Identification, causation, alleviation, and prevention of complications (ICAP): An approach to symptom management in multiple sclerosis. Neurology 2008;71:S14-20.
3. Khan F, Pallant JF, Brand C, Kilpatrick TJ. Effectiveness of rehabilitation in persons with multiple sclerosis: A randomised controlled trial. J Neurol Neurosurg Psychiatry 2008;79:1230-1235
4. Kraft GH, Johnson KL, Yorkston K, Amtmann D, Bamer A, Bombardier C, et al. Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler 2008;14:1292-1297
5. Khan F, Turner-Stokes L, Ng L, Kilpatrick T. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev 2007;2:CD006036.
6. Schapiro RT, Pharmacologic options for the management of multiple sclerosis symptoms. Neurorehabil Neural Repair 2002;16:223-231
7. Brown TR, Kraft GH. Exercise and rehabilitation for individuals with multiple sclerosis. Phys Med Rehabil Clin N Am 2005;16:513-555
8. Higginson IH, Hart S, Burman R, Silber E, Saleem T, Edmonds P. Randomised controlled trail of a new palliative care service: Compliance, recruitment and completeness of follow-up. BMC Palliat Care 2008;7:7.
9. Jonssen A, Dock J, Ravnborg MH. Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurol Scand 1996;93:229-235
10. Benito-Leon J, Morales JM, Rivera-Navarro J, Mitchell A. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil 2003;25:1291-1303
11. Kraft GH. Multiple sclerosis: future directions in the care and the cure. J Neuro Rehabil. 1989;3:61-64
12. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, et al. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 1999;52:57-62.
13. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. Inpatient rehabilitation in multiple sclerosis: Do the Benefits carry over into the community? Neurology 1999;52:50-56
14. Greenspun B, Stineman M, Agri R. Multiple sclerosis and rehabilitation outcome. Arch Phys Med Rehabil 1987;68:434-437
15. Aisen ML, Sevilla D, Fox N. Inpatient rehabilitation for multiple sclerosis. J Neurol Rehabil 1996;10:43-46
16. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 1997;42:236-244
17. Vaney C. Assessing mobility in multiple sclerosis using the Rivermead Mobility Index and gait speed. Clin Rehabil 1996;10:216-226
18. Hadjimichael O. Use of rehabilitation services reported by NARCOMS registrants. Mult Scler Q Rep 2004;23:21-23
19. Fragoso YD, Santana DL, Pinto RC. The positive effects of a physical activity program for multiple sclerosis patients with fatigue. Neurorehabilitation 2008;23:153-157
20. Benedetti MG, Gasparroni V, Stecchi S, Zilioli R, Straudi S, Piperno R. Treadmill exercise in early multiple sclerosis: A case series study. Eur J Phys Rehabil Med 2009 In press.
21. Khan F, Ng L, Turner-Stokes L. Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis. Cochrane Database Syst Rev 2009;1:CD007256
22. Wiles CM. Physiotherapy and related activities in multiple sclerosis. Mult Scler 2008;14:862-871
23. Finlayson M, Garcia JD, Cho C. Occupational therapy service use among people aging with multiple sclerosis. Am J Occup Ther 2008;62:320-328
24. Bombardier CH, Wadhwani R, LaRotonda C. Health promotion in people with multiple sclerosis. Phys Med Rehabil Clin N Am 2005;16:557-570
25. Fisk JD, Ponterfract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994;21:9-14.
26. Schapiro RT. Symptom management in multiple sclerosis. 3rd ed. New York: Demos Medical Publishing; 1998
27. Elkins LE, Pollina DA, Scheffer SR, Krupp LB. Effects of fatigue on cognitive functioning in multiple sclerosis. Neurology 1998;50:A126.
28. Kraft GH, Alquist AD. Effect of microclimate cooling on physical function in multiple sclerosis [abstract]. Mult Scler Clin Lab Res 1996;2:114-115
29. Petajan ET, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996;39:432-441
30. Di Fabio RP, Soderberg, Choi T, Hansen CR, Schapiro RT. Extended outpatient rehabilitation: Its Influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 1998;79:141-146
31. Canadian MS Research Group. A randomized controlled trial of Amantadine in fatigue associated with multiple sclerosis. Can J Neurol Sci 1987;14:273-278
32. Wilkin JA, Sullivan C, Wallen M. Treatment of multiple sclerosisrelated cognitive problems with adjunctive modafinil. Intel J MS Care 2008;10:1-10.
33. Kraft GH, Bowen J. Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study. Neurology 2005;65:1995-1997
34. Petajan JH. Weakness. Multiple sclerosis: Diagnosis, medical management, and rehabilitation. In: Burks JS, Johnson KP, editors. New York: Demos Medical Publishing; 2000.
35. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996;39:432-441
36. Kraft GH, Alquist AD, de Lateur BJ. Effect of resistive exercise on strength in multiple sclerosis. Rehabil Res Dev Rep 1995;33: 329-330
37. Schapiro RT, Soderberg J, Hooley M. The multiple sclerosis achievement center: A maintenance approach toward a chronic progressive form of the disease. J Neurol Rehabil 1988;2:21-23
38. Di Fabio RP, Soderberg J, Choi T, Hansen CR, Schapiro RT. Extended outpatient rehabilitation: Its Influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 1998;79:141-146
39. Di Fabio RP, Choi T, Soderberg J, Hansen CR. Health-related quality of life for patients with progressive multiple sclerosis: Influence of rehabilitation. Phys Ther 1997;77:1704-1716
40. Patti F, Ciancio MR, Cacopardo M, Reggio E, Fiorilla T, Palermo F, et al. Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients: A randomized controlled trial. J Neurol 2003;250:861-866
41. Lord SE, Wade DT, Halligan PW. A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: A pilot randomized controlled study. Clin Rehabil 1998;12:477-486
42. Husted C, Pham L, Hekking A, Niederman R. Improving quality of life for people with chronic conditions: The example of t.ai chi and multiple sclerosis. Altern Ther Health Med 1999;5:70-74
43. Gehlsen G, Beekman K, Assmann N, Winant D, Seidle M, Carter A. Gait characteristics in multiple sclerosis: Progressive changes and effects of exercise on parameters. Arch Phys Med Rehabil 1986;67:536-539
44. Haselkorn JK, Leer SE, Hall JA, Pate DJ. Mobility. Multiple sclerosis: Diagnosis, medical management, and rehabilitation. In: Burks JS, Johnson KP, editors. New York: Demos Medical Publishing; 2000.
45. Rao SM, Leo GJ, Bernadin L, Unverzagtf. Cognitive dysfunction in multiple sclerosis, 1 frequency, patterns, and prediction. Neurology 1991;41:685-691
46. Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM. Neuro-psychological findings in relapsing/remitting and chronic/progressive multiple sclerosis. J Consult Clin Psychol 1985;53:103-110
47. LaRocca NG. Cognitive and emotional disorders. Multiple sclerosis: Diagnosis, medical management, and rehabilitation. In: Burks JS, Johnson KP, editors. New York: Demos Medical Publishing; 2000.
48. Fisher JS, Priore RL, Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, et al. Neuropsychological affects of interferon beta-1a in relapsing remitting multiple sclerosis. Ann Neurol 2000;48:885-892
49. Krupp LB, Christodoulouc, Melville P, Scherl WF, MacAllister WS, Elkins LE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004;63:1579-1585
50. Pliskin NH, Homer DP, Goldstein DS, Towle VL, Reder AT, Noronha A, et al. Improved delayed visual reproduction tests performance in multiple sclerosis patients receiving an interferon beta-1b. Neurology 1996;47:1463-1468
51. Freedman MS, Kappos L, Polman CH, et al. Impact of early interferon beta-1b treatment on disease evolution over Five years in patients with a first event suggestive of multiple sclerosis. Multiple Sclerosis 2008;S295,P901.
52. Havardova E. The affects of natalizumad on a test of cognitive function in patients with relapsing multiple sclerosis (MS). Eur J Neurol 2006;13:307.
53. Indaco A, Iachetta C, Socci L, Carrieri PB. Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol 1994;16:97-102.
54. Steneger E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand 1991;84:197-200.
55. Moulin D, Foley K, Ebers G. Pain syndromes in multiple sclerosis. Neurology 1998;38:1830-1834
56. Osterman P, Westerberg C. Paroxysmal attacks in multiple sclerosis. Brain 1975;98:189-202.
57. Clifford DB, Trotter JL. Pain in multiple sclerosis. Arch Neurol 1994;41:1270-1272
58. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, et al. Depression in multiple sclerosis. Neurology 1996;46:628-632
59. Sadovnick AD, Eisenk, Ebers GC, Paty DW. Causes of death in patients attending multiple sclerosis clinics. Neurology 1991;41:1193-1196
60. Beck AT, Ward CH, Mendelson M, Mock J, Erbauch J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
61. Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990;147:1493-1497
62. Chia Y, Fowler C, Kamm M, Henry MM, Lemieux MC, Swash M. Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. J Neurol 1995;242:105-108
63. Hinds J, Eidelman B, Wald A. Prevalence of bowel dysfunction in multiple sclerosis. Gastroenterology 1990;98:1532-1542
64. Lilius HG, Valtonen EJ, Wikstrom J. Sexual problems in patients suffering from multiple sclerosis. J Chron Dis 1976;29:643-647
65. Lilius HG, Valtonen EJ, Wikstrom J. Sexual problems in patients suffering from multiple sclerosis. Scand J Soc Med 1976;4:41-44
66. Mattson D, Petrie M, Srivastava DK, McDermott M. Multiple sclerosis: Sexual dysfunction and its response to medications. Arch Neurol 1995;52:862-868
67. McCabe MP, McDonald E, Deeks AA. The impact of multiple sclerosis on sexuality and relationships. J Sex Res 1996;33:241-248
68. Valleroy ML, Kraft GH. Sexual dysfunction in multiple sclerosis. Arch Phys Med Rehabil 1984;65:125-128
69. Silbiger M, Piknielney R, Donner M. Neuromuscular disorders affecting pharynx: Cineradiographic analysis. Invest Radiol 1967;2:442-448
70. Logemann JA. Evaluation and treatment of swallowing disorders. 2nd ed. Austin, TX: Pro-Ed, 1998.
71. Fabiszak A. Swallowing patterns in neurologically normal subjects and two subgroups of multiple sclerosis patients. Unpublished doctoral dissertation. Evanstron, IL: Northwestern University; 1987.
72. Cobble ND, Wangaard C, Kraft GH, Burks JS. Rehabilitation of the patient with multiple sclerosis. In: Delisa JA, et al, editors. Rehabilitation medicine: Principles and practice. Philadelphia: J.B. Lippincott; 1988. p. 628.